{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:35:47Z","timestamp":1791182147100,"version":"4.1.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/cco.0b013e32834ec015","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T07:18:42Z","timestamp":1328599122000},"page":"170-175","source":"Crossref","is-referenced-by-count":9,"title":["Cancer stem cells"],"prefix":"10.1097","volume":"24","author":[{"given":"Gabriel","family":"Ghiaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/bjc.1953.8","article-title":"A new theory on cancer-inducing mechanism.","volume":"7","author":"Nordling","year":"1953","journal-title":"Br J Cancer"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/bjc.1969.41","article-title":"The two hit and multiple hit theories of carcinogenesis.","volume":"23","author":"Ashley","year":"1969","journal-title":"Br J Cancer"},{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma.","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations.","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1073\/pnas.58.4.1468","article-title":"Clonal origin of chronic myelocytic leukemia in man.","volume":"58","author":"Fialkow","year":"1967","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1182\/blood.V81.11.2898.2898","article-title":"BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia.","volume":"81","author":"Bedi","year":"1993","journal-title":"Blood"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.V87.4.1539.bloodjournal8741539","article-title":"Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.","volume":"87","author":"Sirard","year":"1996","journal-title":"Blood"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajh.21915","article-title":"Characterization of chronic myeloid leukemia stem cells.","volume":"86","author":"Gerber","year":"2011","journal-title":"Am J Hematol"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI41495","article-title":"Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NODSCIDIL2Rgammac-deficient mice.","volume":"121","author":"Sarry","year":"2011","journal-title":"J Clin Invest"},{"key":"R12-11-20210128","first-page":"2187","article-title":"Growth characteristics of a mouse plasma cell tumor.","volume":"28","author":"Bergsagel","year":"1968","journal-title":"Cancer Res"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI108839","article-title":"Primary bioassay of human myeloma stem cells.","volume":"60","author":"Hamburger","year":"1977","journal-title":"J Clin Invest"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2003-09-3064","article-title":"Characterization of clonogenic multiple myeloma cells.","volume":"103","author":"Matsui","year":"2004","journal-title":"Blood"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","article-title":"Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.","volume":"68","author":"Matsui","year":"2008","journal-title":"Cancer Res"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/stem.5530060606","article-title":"L-428 Reed-Sternberg cells and mononuclear Hodgkins cells arise from a single cloned mononuclear cell.","volume":"6","author":"Newcom","year":"1988","journal-title":"Int J Cell Cloning"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1182\/blood-2008-11-189688","article-title":"Circulating clonotypic B cells in classical Hodgkins lymphoma.","volume":"113","author":"Jones","year":"2009","journal-title":"Blood"},{"key":"R18-11-20210128","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/blood-2010-02-268375","article-title":"Mantle cell lymphoma activation enhances bortezomib sensitivity.","volume":"116","author":"Brennan","year":"2010","journal-title":"Blood"},{"key":"R19-11-20210128","first-page":"75","article-title":"Natural history of and therapy for the indolent non-Hodgkins lymphomas.","volume":"20","author":"Horning","year":"1993","journal-title":"Semin Oncol"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1200\/JCO.2004.05.111","article-title":"Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials.","volume":"22","author":"Durie","year":"2004","journal-title":"J Clin Oncol"},{"key":"R21-11-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199607113350204","article-title":"A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome.","volume":"335","author":"Attal","year":"1996","journal-title":"N Engl J Med"},{"key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.2005.04.5807","article-title":"Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.","volume":"24","author":"Barlogie","year":"2006","journal-title":"J Clin Oncol"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.md.0000173272.71949.a1","article-title":"A meta-analysis on data from 575 patients with multiple myeloma randomly assigned to either high-dose therapy or conventional therapy.","volume":"84","author":"Levy","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbmt.2006.09.010","article-title":"High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials.","volume":"13","author":"Koreth","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R26-11-20210128","first-page":"583","article-title":"Cancer stem cells: are we missing the target J Natl Cancer I","volume":"96","author":"Jones","year":"2004","journal-title":"nst"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1182\/blood-2005-06-2517","article-title":"The paradox of response and survival in cancer therapeutics.","volume":"107","author":"Huff","year":"2006","journal-title":"Blood"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1158\/0008-5472.CAN-07-1971","article-title":"The fuzzy math of solid tumor stem cells: a perspective.","volume":"67","author":"Kern","year":"2007","journal-title":"Cancer Res"},{"key":"R29-11-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1142596","article-title":"Tumor growth need not be driven by rare cancer stem cells.","volume":"317","author":"Kelly","year":"2007","journal-title":"Science"},{"key":"R30-11-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","article-title":"Efficient tumour formation by single human melanoma cells.","volume":"456","author":"Quintana","year":"2008","journal-title":"Nature"},{"key":"R31-11-20210128","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","article-title":"Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.","volume":"106","author":"Creighton","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R32-11-20210128","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMoa0912228","article-title":"Persistent malignant stem cells in del(5q) myelodysplasia in remission.","volume":"363","author":"Tehranchi","year":"2010","journal-title":"N Engl J Med"},{"key":"R34-11-20210128","doi-asserted-by":"crossref","first-page":"240a","DOI":"10.1182\/blood.V118.21.240.240","article-title":"The clinical relevance of acute myeloid leukemia stem cells.","volume":"118","author":"Gerber","year":"2011","journal-title":"Blood"},{"key":"R35-11-20210128","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"key":"R36-11-20210128","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2141.2001.02726.x","article-title":"Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres.","volume":"113","author":"Gahrton","year":"2001","journal-title":"Br J Haematol"},{"key":"R37-11-20210128","first-page":"1997","article-title":"Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.","volume":"100","author":"Sierra","year":"2002","journal-title":"Blood"},{"key":"R38-11-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"R39-11-20210128","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/cncr.24198","article-title":"Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.","volume":"115","author":"Jabbour","year":"2009","journal-title":"Cancer"},{"key":"R40-11-20210128","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbmt.2010.10.008","article-title":"5-Azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation.","volume":"17","author":"Bolanos-Meade","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R41-11-20210128","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1182\/blood-2009-03-208298","article-title":"Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation.","volume":"113","author":"Metzelder","year":"2009","journal-title":"Blood"},{"key":"R42-11-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells.","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"R43-11-20210128","first-page":"7283","article-title":"Does the reservoir for self-renewal stem from the ends O","volume":"23","author":"Harrington","year":"2004","journal-title":"ncogene"},{"key":"R44-11-20210128","doi-asserted-by":"crossref","first-page":"e12487","DOI":"10.1371\/journal.pone.0012487","article-title":"Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms.","volume":"5","author":"Brennan","year":"2010","journal-title":"PLoS One"},{"key":"R45-11-20210128","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1073\/pnas.0611682104","article-title":"Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma.","volume":"104","author":"Peacock","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R46-11-20210128","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2005.11.020","article-title":"Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.","volume":"123","author":"Hao","year":"2005","journal-title":"Cell"},{"key":"R47-11-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0268-960X(03)00020-1","article-title":"Dyskeratosis congenita: its link to telomerase and aplastic anaemia.","volume":"17","author":"Dokal","year":"2003","journal-title":"Blood Rev"},{"key":"R48-11-20210128","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.ejca.2006.01.040","article-title":"Telomeres and telomerase in cancer stem cells.","volume":"42","author":"Ju","year":"2006","journal-title":"Eur J Cancer"},{"key":"R49-11-20210128","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0092-8674(00)80761-8","article-title":"Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta23) cancer-prone mouse.","volume":"97","author":"Greenberg","year":"1999","journal-title":"Cell"},{"key":"R50-11-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/88871","article-title":"Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.","volume":"28","author":"Rudolph","year":"2001","journal-title":"Nat Genet"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCO.0b013e32834ec015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:33:33Z","timestamp":1786048413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001622-201203000-00011"}},"subtitle":["relevance to clinical transplantation"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0b013e32834ec015","relation":{},"ISSN":["1040-8746"],"issn-type":[{"value":"1040-8746","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}